Reduced-Dose Chemotherapy Followed By Blinatumomab As Induction Therapy in Treatment of Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia - Interim Results from a Multicenter, Single-Arm, Phase 2 Study

被引：0

作者：

Lu, Jing ^{[1
]}

Wang, Ying ^{[2
]}

Qiu, Huiying ^{[3
]}

Zhou, Xin ^{[4
]}

Lu, Xuzhang ^{[5
]}

Miao, Miao ^{[6
]}

Gu, Bin ^{[1
]}

Hu, Xiaohui ^{[1
]}

Wu, Depei ^{[6
]}

Chen, Suning ^{[1
]}

机构：

[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis,Dept Hematol, Suzhou, Peoples R China

[2] Soochow Univ, Affiliated Hosp 1, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol, Suzhou, Peoples R China

[3] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol,Natl Clin Res Ctr Hematol Di, Dept Hematol,Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China

[4] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Hematol, Wuxi, Jiangsu, Peoples R China

[5] Nanjing Med Univ, Affiliated Changzhou Hosp 2, Dept Hematol, Changzhou, Jiangsu, Peoples R China

[6] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-174831

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] Reduced-dose chemotherapy followed by blinatumomab in induction therapy for newly diagnosed B-cell acute lymphoblastic leukemia
Lu, Jing
Zhou, Huifen
Zhou, Xin
Yang, Yonggong
Tong, Laigen
Miao, Miao
Yang, Xiaofei
Chen, Suning
CANCER MEDICINE, 2024, 13 (05):
[2] Reduced-dose chemotherapy followed by blinatumomab for newly diagnosed philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia: a propensity-matched comparison with hyper-CVAD
Lu, Jing
Zhu, Yu
Qiu, Huiying
Wang, Ying
Zhou, Xin
Dai, Haiping
Lu, Xuzhang
Gu, Bin
Hong, Ming
Miao, Miao
Lu, Ruinan
Wang, Jun
Wu, Qian
Xue, Mengxing
Wang, Yun
Deng, Ailing
Shen, Yaoyao
Liu, Yin
Dou, Xueqing
Lei, Yutian
Yang, Xiaofei
Chen, Suning
DISCOVER ONCOLOGY, 2025, 16 (01)
[3] Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial
Lu, Jing
Qiu, Huiying
Wang, Ying
Zhou, Xin
Dai, Haiping
Lu, Xuzhang
Yang, Xiaofei
Gu, Bin
Hong, Ming
Miao, Miao
Lu, Ruinan
Wang, Jun
Wu, Qian
Xue, Mengxing
Wang, Yun
Deng, Ailing
Shen, Yaoyao
Liu, Yin
Dou, Xueqing
Lei, Yutian
Wu, Depei
Zhu, Yu
Chen, Suning
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
[4] Blinatumomab for the Treatment of Philadelphia Chromosome-Negative, Precursor B-cell Acute Lymphoblastic Leukemia
Wolach, Ofir
Stone, Richard M.
CLINICAL CANCER RESEARCH, 2015, 21 (19) : 4262 - 4269
[5] Hyper-CVAD and Sequential Blinatumomab in Adults with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia: Results from a Phase II Study
Short, Nicholas J.
Kantarjian, Hagop M.
Ravandi, Farhad
Huang, Xuelin
Ferrajoli, Alessandra
Kadia, Tapan M.
Thompson, Philip A.
Alvarado, Yesid
Jain, Nitin
Yilmaz, Musa
Khoury, Joseph D.
Jorgensen, Jeffrey L.
Wang, Sa A.
Kornblau, Steven M.
Konopleva, Marina
Garcia-Manero, Guillermo
Schroeder, Heather M.
Kwari, Monica
Paul, Shilpa
Nwakanme, Benjamin
Loiselle, Christopher
Garris, Rebecca
O'Brien, Susan M.
Jabbour, Elias
BLOOD, 2020, 136
[6] Updated Results from a Phase II Study of Hyper-CVAD with Sequential Blinatumomab in Adults with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
Short, Nicholas J.
Kantarjian, Hagop
Ravandi, Farhad
Huang, Xuelin
Thompson, Philip A.
Ferrajoli, Alessandra
Kadia, Tapan M.
Jain, Nitin
Alvarado, Yesid
Yilmaz, Musa
Khoury, Joseph D.
Jorgensen, Jeffrey L.
Wang, Sa A.
Kornblau, Steven M.
Konopleva, Marina
Garcia-Manero, Guillermo
Garris, Rebecca
Schroeder, Heather M.
Milton, Anna
Rivera, Juan
Banks, Glenda
Jabbour, Elias J.
BLOOD, 2021, 138
[7] SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
Advani, Anjali S.
Moseley, Anna
O'Dwyer, Kristen M.
Wood, Brent L.
Fang, Min
Wieduwilt, Matthew J.
Aldoss, Ibrahim
Park, Jae H.
Klisovic, Rebecca B.
Baer, Maria R.
Stock, Wendy
Bhave, Rupali R.
Othus, Megan
Harvey, Richard C.
Willman, Cheryl L.
Litzow, Mark R.
Stone, Richard M.
Sharon, Elad
Erba, Harry P.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (14) : 1574 - +
[8] Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial
Jabbour, Elias
Short, Nicholas J.
Jain, Nitin
Thompson, Philip A.
Kadia, Tapan M.
Ferrajoli, Alessandra
Huang, Xuelin
Yilmaz, Musa
Alvarado, Yesid
Patel, Keyur P.
Garcia-Manero, Guillermo
Macaron, Walid
Garris, Rebecca
Konopleva, Marina
Ravandi, Farhad
Kantarjian, Hagop
LANCET HAEMATOLOGY, 2022, 9 (12): : E878 - E885
[9] Hyper-CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
Kantarjian, Hagop
Short, Nicholas J.
Jain, Nitin
Haddad, Fadi G.
Kadia, Tapan
Yilmaz, Musa
Ferrajoli, Alessandra
Sasaki, Koji
Alvarado, Yesid
Pemmaraju, Naveen
Senapati, Jayastu
Garris, Rebecca
Ravandi, Farhad
Jabbour, Elias
AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (03) : 402 - 407
[10] Updated Results from a Phase II Study of Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
Short, Nicholas J.
Kantarjian, Hagop
Ravandi, Farhad
Huang, Xuelin
Jain, Nitin
Kadia, Tapan M.
Khoury, Joseph D.
Jorgensen, Jeffrey L.
Wang, Sa A.
Alvarado, Yesid
Burger, Jan A.
Daver, Naval
Borthakur, Gautam
DiNardo, Courtney D.
Konopleva, Marina
Pemmaraju, Naveen
Garcia-Manero, Guillermo
Wierda, William G.
Kornblau, Steven M.
Jacob, Jovitta
Kwari, Monica
Rausch, Caitlin R.
Loiselle, Christopher
Milton, Anna
Rivera, Juan
Garris, Rebecca
O'Brien, Susan M.
Jabbour, Elias J.
BLOOD, 2021, 138

← 1 2 3 4 5 →